Product Description:
The historical significance of lymphoma cytogenetics is accentuated by the fact that a distinct chromosomal abnormality, ?14q+?, was first identified and associated with Burkitt lymphoma.1 This triggered numerous investigations in search of specific chromosomal abnormalities in various malignancies,. However, the maximum success came from chromosome studies in hematologic malignancies because they readily lent themselves to cytogenetic analysis. The characterization of t(8;14)(q24;q32) and its association with Burkitt lymphoma2 led to focused genetic studies in various subtypes of lymphomas. Since then, cytogenetics has played a crucial role in providing substantial insight into the genetic mechanisms of lymphomagenesis. Consistent chromosomal alterations in lymphomas, specifically, non-Hodgkin lymphomas (NHLs), have greatly impacted the classification of NHLs in general, especially the B-cell lymphomas,3-5.
Keyword(s):
Lymphoma, Cytogenetics, Fluorescence in situ hybridization, Microarray, Disease progression